Abiopharma

🔍 FMR LLC (Executive)

Company: Beam Therapeutics Inc. (BEAM)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Sold 33,372 shares of Common Stock at $35.12 per share (Direct)
  Date: 2026-06-25 | Code: S | equity_swap_involved: false | shares_owned_after: 1,106,071.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 251,488 shares of Common Stock at $35.26 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 854,583.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: FMR Capital, Inc. | shares_owned_after: 14.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: Shares held by persons and entities whose shares are subject to reporting by the undersigned. | shares_owned_after: 841,231.00

Footnotes:

• F1: The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.39. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information.
• F2: The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $35.00 to $35.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information.
• REMARKS: Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund V LP is F-Prime Capital Partners Healthcare Advisors Fund V LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. FMR Capital, Inc. is a wholly owned subsidiary of FMR LLC.